Karuna Therapeutics Inc (KRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KRTX | BMRN | HALO | ||
| Company | Karuna Therapeutics Inc | Biomarin Pharmaceuticals | Halozyme Therapeutic | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 329.75 | 66.57 | 108.00 | ||
| High | 329.99 | 67.18 | 109.10 | ||
| Low | 329.75 | 64.71 | 107.05 | ||
| Last | 329.83 | 65.07 | 108.64 | ||
| Change | +0.09 | -1.63 | +0.47 | ||
| Percent Change | +0.03% | -2.44% | +0.43% | ||
| Volume | 1,868,500 | 2,264,164 | 2,090,511 | ||
| 20-Day Average Volume | 585,565 | 2,340,178 | 2,457,256 | ||
| Previous | 329.74 | 66.70 | 108.17 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 319.40 | 64.85 | 95.77 | ||
| 20-Day Raw Stochastic | 99.53% | 51.12% | 98.35% | ||
| 20-Day Relative Strength | 74.08 | 55.33 | 77.19 | ||
| Weighted Alpha | +52.60 | +18.14 | +63.76 | ||
| Today's Opinion | 100% Buy | 96% Buy | 100% Buy | ||
| Yesterday's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 72% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.09% since 03/08/24 | -2.36% since 08/17/26 | +5.48% since 08/17/26 | ||
| Low | 318.52 on 03/11/24 | 64.71 on 08/24/26 | 102.39 on 08/18/26 | ||
| High | 329.99 on 03/15/24 | 69.62 on 08/19/26 | 109.10 on 08/24/26 | ||
| 1-Month | |||||
| %Chg | +3.27% since 02/15/24 | +9.67% since 07/24/26 | +32.60% since 07/24/26 | ||
| Low | 296.06 on 02/26/24 | 58.89 on 08/06/26 | 81.21 on 07/30/26 | ||
| High | 329.99 on 03/15/24 | 70.98 on 08/12/26 | 109.10 on 08/24/26 | ||
| 3-Month | |||||
| %Chg | +50.08% since 12/15/23 | +20.30% since 05/22/26 | +59.02% since 05/22/26 | ||
| Low | 210.14 on 12/20/23 | 52.19 on 05/28/26 | 65.60 on 06/02/26 | ||
| High | 329.99 on 03/15/24 | 70.98 on 08/12/26 | 109.10 on 08/24/26 | ||
| 6-Month | |||||
| %Chg | +82.33% since 09/15/23 | +3.91% since 02/24/26 | +54.41% since 02/24/26 | ||
| Low | 158.38 on 10/03/23 | 49.26 on 05/18/26 | 61.33 on 03/27/26 | ||
| High | 329.99 on 03/15/24 | 70.98 on 08/12/26 | 109.10 on 08/24/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 12,582,351 | 12,911,385 | 12,277,079 | ||
| Shares Outstanding, K | 38,148 | 193,574 | 113,498 | ||
| Annual Sales, $M | 650,000 | 3,221,250,000 | 1,396,610,000 | ||
| Annual Net Income, $M | -433,680,000 | 348,900,000 | 316,890,000 | ||
| Last Qtr Sales, $M | 0 | 989,710,000 | 481,000,000 | ||
| Last Qtr Income, $M | -113,820,000 | 44,760,000 | 229,910,000 | ||
| 60-Month Beta | 1.18 | 0.24 | 0.85 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -3.01 on 02/22/24 | 1.20 on 08/06/26 | 2.28 on 08/06/26 | ||
| Latest Earnings Date | 05/02/24 | 10/26/26 | 11/02/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 40.29 | 21.53 | ||